MyoKardia CEO Tassos Gianakakos' 2019 pay rises 14% to $10M
MyoKardia reports 2019 executive compensation
By ExecPay News
Published: April 24, 2020
MyoKardia reported fiscal year 2019 executive compensation information on April 24, 2020.
In 2019, six MyoKardia executives received on average a compensation package of $4.2M, a 2% decrease compared to previous year.
Average pay of disclosed executives at MyoKardia
Tassos Gianakakos, Chief Executive Officer, received $10M in total, which increased by 14% compared to 2018. 58% of Gianakakos' compensation, or $6M, was in option awards. Gianakakos also received $376K in non-equity incentive plan, $610K in salary, $3.3M in stock awards, as well as $1K in other compensation.
For fiscal year 2019, the median employee pay was $268,172 at MyoKardia. Therefore, the ratio of Tassos Gianakakos' pay to the median employee pay was 38 to one.
William Fairey, Executive Vice President, Chief Commercial Officer, received a compensation package of $4.1M. 44% of the compensation package, or $1.8M, was in option awards.
June Lee, Executive Vice President, Chief Development Officer, earned $3M in 2019, a 13% decrease compared to previous year.
Robert McDowell, Chief Scientific Officer, received $2.8M in 2019, which increases by 10% compared to 2018.
Jake Bauer, Chief Business Officer, earned $2.8M in 2019, a 39% increase compared to previous year.
Taylor C. Harris, Chief Financial Officer, received $2.5M in 2019, which decreases by 43% compared to 2018.
Related executives
Tassos Gianakakos
MyoKardia
Chief Executive Officer
Taylor Harris
MyoKardia
Chief Financial Officer
William Fairey
MyoKardia
Executive Vice President, Chief Commercial Officer
Jake Bauer
MyoKardia
Chief Business Officer
Robert McDowell
MyoKardia
Chief Scientific Officer
June Lee
MyoKardia
Executive Vice President, Chief Development Officer
You may also like
Source: SEC filing on April 24, 2020.